Role of endocannabinoids in regulating drug dependence

References

• AnggadiredjaKNakamichiMHiranitaT2004Endocannabinoid system modulates relapse to methamphetamine seeking: possible mediation by the arachidonic acid cascadeNeuropsychopharmacology291470815085091
   PubMed Web of Science ®Google Scholar
• AnthenelliRMDespresJP2004Effects of Rimonabant in the reduction of major cardiovascular risk factors Results from the STRATUS-US trial (smoking cessation in smokers motivated to quit)In american college of cardiology 53rd annual scientific session2004, Mar 7–10New Orleans, LA
   Google Scholar
• ArnoneMMaruaniJChaperonF1997Selective inhibition of sucrose and ethanol intake by SR141716, an antagonist of central cannabinoid (CB1) receptorsPsychopharmacology13210469272766
   PubMed Web of Science ®Google Scholar
• BalerioGNAsoEBerrenderoF2004Delta9-tetrahydrocannabinol decreases somatic and motivational manifestations of nicotine withdrawal in miceEur J Neurosci2027374815548217
   PubMed Web of Science ®Google Scholar
• BasavarajappaBSSaitoMCooperTB1997Activation of arachidonic acid-specific phospholipase A2 in human neuroblastoma cells after chronic alcohol exposure: prevention by GM1 gangliosideAlcohol Clin Exp Res2111992039347079
   PubMed Web of Science ®Google Scholar
• BasavarajappaBSCooperTBHungundBL1998Effect of chronic ethanol exposure on mouse brain arachidonic acid specific phospholipase A2Biochem Pharmacol55515219514087
   PubMed Web of Science ®Google Scholar
• BasavarajappaBSHungundBL1999aChronic ethanol increases the cannabinoid receptor agonist anandamide and its precursor N-arachidonoyl-phosphatidyl-ethanolamine in SK-N-SH cellsJ Neurochem7252289930723
   PubMed Web of Science ®Google Scholar
• BasavarajappaBSHungundBL1999bDown-regulation of cannabinoid receptor agonist-stimulated [35S]GTP gamma S binding in synaptic plasma membrane from chronic ethanol exposed mouseBrain Res81589979974126
   PubMed Web of Science ®Google Scholar
• BasavarajappaBSSaitoMCooperTB2003Chronic ethanol inhibits the anandamide transport and increases extracellular anandamide levels in cerebellar granule neuronsEur J Pharmacol466738312679143
   PubMed Web of Science ®Google Scholar
• BasavarajappaBSYalamanchiliRCravattBF2006Increased ethanol consumption and preference and decreased ethanol sensitivity in female FAAH knockout miceNeuropharmacology508344416448676
   PubMed Web of Science ®Google Scholar
• BisognoTLigrestiADi MarzoV2005The endocannabinoid signalling system: biochemical aspectsPharmacol Biochem Behav812243815935454
   PubMed Web of Science ®Google Scholar
• BraidaDIosueSPegoriniS20053,4-Methylenedioxymethamphetamine-induced conditioned place preference (CPP) is mediated by endocannabinoid systemPharmacol Res511778215629265
   PubMed Web of Science ®Google Scholar
• BraidaDPozziMCavalliniR2001Conditioned place preference induced by the cannabinoid agonist CP 55,940: interaction with the opioid systemNeuroscience104923611457579
   PubMed Web of Science ®Google Scholar
• BraidaDSalaM2002Role of the endocannabinoid system in MDMA intracerebral self-administration in ratsBr J Pharmacol13610899212163340
   PubMed Web of Science ®Google Scholar
• CailleSParsonsLH2003SR141716A reduces the reinforcing properties of heroin but not heroin-induced increases in nucleus accumbens dopamine in ratsEur J Neurosci183145914656311
   PubMed Web of Science ®Google Scholar
• CailleSParsonsLH2004Intravenous heroin self-administration decreases GABA efflux in the ventral pallidum: an in vivo microdialysis study in ratsEur J Neurosci20593615233770
   PubMed Web of Science ®Google Scholar
• CailleSParsonsLH2006Cannabinoid modulation of opiate reinforcement through the ventral striatopallidal pathwayNeuropsychopharmacology318041316123766
   PubMed Web of Science ®Google Scholar
• CamiJFarreM2003Drug addictionN Engl J Med3499758612954747
   PubMed Web of Science ®Google Scholar
• CastaneAValjentELedentC2002Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinenceNeuropharmacology438576712384171
   PubMed Web of Science ®Google Scholar
• CastaneARobledoPMatifasA2003Cannabinoid withdrawal syndrome is reduced in double mu and delta opioid receptor knockout miceEur J Neurosci17155912534979
   PubMed Web of Science ®Google Scholar
• ChaperonFThiebotMH1999Behavioral effects of cannabinoid agents in animalsCrit Rev Neurobiol132438110803637
   PubMedGoogle Scholar
• CippitelliABilbaoAHanssonAC2005Cannabinoid CB1 receptor antagonism reduces conditioned reinstatement of ethanol-seeking behavior in ratsEur J Neurosci2122435115869521
   PubMed Web of Science ®Google Scholar
• CohenCPerraultGGriebelG2005Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB1) receptor antagonist, Rimonabant (SR141716)Neuropsychopharmacology301455515292905
   PubMed Web of Science ®Google Scholar
• CohenCPerraultGVoltzC2002SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in ratsBehav Pharmacol134516312394421
   PubMed Web of Science ®Google Scholar
• ColomboGAgabioRFaM1998Reduction of voluntary ethanol intake in ethanol-preferring sP rats by the cannabinoid antagonist SR141716Alcohol Alcohol33126309566474
   PubMed Web of Science ®Google Scholar
• ColomboGSerraSBrunettiG2002Stimulation of voluntary ethanol intake by cannabinoid receptor agonists in ethanol-preferring sP ratsPsychopharmacology159181711862347
   PubMed Web of Science ®Google Scholar
• ColomboGVaccaGSerraS2004Suppressing effect of the cannabinoid CB1 receptor antagonist, SR141716, on alcohol’s motivational properties in alcohol-preferring ratsEur J Pharmacol4981192315363985
   PubMed Web of Science ®Google Scholar
• CossuGLedentCFattoreL2001Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuseBehav Brain Res11861511163634
   PubMed Web of Science ®Google Scholar
• De VriesTJHombergJRBinnekadeR2003Cannabinoid modulation of the reinforcing and motivational properties of heroin and heroin-associated cues in ratsPsychopharmacology168164912669182
   PubMed Web of Science ®Google Scholar
• De VriesTJShahamYHombergJR2001A cannabinoid mechanism in relapse to cocaine seekingNat Med71151411590440
   PubMed Web of Science ®Google Scholar
• DeikelSMCarderB1976Attentuation of precipitated abstinence in methadone-dependent rats by delta9-THCPsychopharmacol Commun2615959602
   PubMedGoogle Scholar
• Del ArcoINavarroMBilbaoA2002Attenuation of spontaneous opiate withdrawal in mice by the anandamide transport inhibitor AM404Eur J Pharmacol454103412409011
   PubMed Web of Science ®Google Scholar
• De VriesTJSchoffelmeerAN2005Cannabinoid CB1 receptors control conditioned drug seekingTrends Pharmacol Sci268420615992935
   PubMed Web of Science ®Google Scholar
• Di ChiaraG1999Drug addiction as dopamine-dependent associative learning disorderEur J Pharmacol375133010443561
   PubMed Web of Science ®Google Scholar
• FattoreLDeianaSSpanoSM2005Endocannabinoid system and opioid addiction: behavioural aspectsPharmacol Biochem Behav813435915935459
   PubMed Web of Science ®Google Scholar
• FattoreLMartellottaMCCossuG1999CB1 cannabinoid receptor agonist WIN 55,212-2 decreases intravenous cocaine self-administration in ratsBehav Brain Res104141611125733
   PubMed Web of Science ®Google Scholar
• FattoreLSpanoMSCossuG2003Cannabinoid mechanism in reinstatement of heroin-seeking after a long period of abstinence in ratsEur J Neurosci171723612752390
   PubMed Web of Science ®Google Scholar
• FattoreLSpanoMSDeianaS2006An endocannabinoid mechanism in relapse to drug seeking: A review of animal studies and clinical perspectivesBrain Res Brain Res Rev[Epub 11 Jul ahead of print doi:10.1016/j.brainresrev.2006.05.003]
   Google Scholar
• ForgetBHamonMThiebotMH2005Cannabinoid CB1 receptors are involved in motivational effects of nicotine in ratsPsychopharmacology1817223415986197
   PubMed Web of Science ®Google Scholar
• FreedlandCSSharpeALSamsonHH2001Effects of SR141716A on ethanol and sucrose self-administrationAlcohol Clin Exp Res252778211236843
   PubMed Web of Science ®Google Scholar
• FrideEMechoulamRMaldonadoR2003New advances in the identification and physiological role of the different components of the endogenous cannabinoidi systemMolecular biology of drug addictionHumana Press17398
   Google Scholar
• FrideE2005Endocannabinoids in the central nervous system: from neuronal networks to behaviorCurr Drug Targets CNS Neurol Disord46334216375681
   PubMedGoogle Scholar
• GallateJEMcGregorIS1999The motivation for beer in rats: effects of ritanserin, naloxone and SR141716Psychopharmacology142302810208323
   PubMed Web of Science ®Google Scholar
• GallateJESaharovTMalletPE1999Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonistEur J Pharmacol3702334010334497
   PubMed Web of Science ®Google Scholar
• GardnerE2005Endocannabinoid signaling system and brain reward: emphasis on dopaminePharmacol Biochem Behav812638415936806
   PubMed Web of Science ®Google Scholar
• GessaGLSerraSVaccaG2005Suppressing effect of the cannabinoid CB1 receptor antagonist, SR147778, on alcohol intake and motivational properties of alcohol in alcohol-preferring sP ratsAlcohol Alcohol40465315582988
   PubMed Web of Science ®Google Scholar
• GhozlandSMatthesHWSimoninF2002Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptorsJ Neurosci2211465411826143
   PubMed Web of Science ®Google Scholar
• GonzalezSCebeiraMFernandez-RuizJ2005Cannabinoid tolerance and dependence: a review of studies in laboratory animalsPharmacol Biochem Behav813001815919107
   PubMed Web of Science ®Google Scholar
• GonzalezSFernandez-RuizJSparpaglioneV2002Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB(1) receptor binding and mRNA levelsDrug Alcohol Depend66778411850139
   PubMed Web of Science ®Google Scholar
• GonzalezSSchmidPCFernandez-RuizJ2003Region-dependent changes in endocannabinoid transmission in the brain of morphine-dependent ratsAddict Biol81596612850774
   PubMed Web of Science ®Google Scholar
• HanssonACBermudez-SilvaFJMalinenH2006Genetic impairment of frontocortical endocannabinoid degradation and high alcohol preference [online]Accessed 28 December 2005 URL: http://www.acnp.org/citations/NPP122805050541/default.pdf
   Google Scholar
• HineBTorrelioMGershonS1975Attenuation of precipitated abstinence in methadone-dependent rats by delta 9-THCPsychopharmacol Commun1275831241452
   PubMedGoogle Scholar
• HouchiHBabovicDPierreficheO2005CB1 receptor knockout mice display reduced ethanol-induced conditioned place preference and increased striatal dopamine D2 receptorsNeuropsychopharmacology303394915383833
   PubMed Web of Science ®Google Scholar
• HymanSEMalenkaRC2001Addiction and the brain: the neurobiology of compulsion and its persistenceNat Rev Neurosci269570311584307
   PubMed Web of Science ®Google Scholar
• JustinovaZTandaGMunzarP2004The opioid antagonist naltrexone reduces the reinforcing effects of Delta 9 tetrahydrocannabinol (THC) in squirrel monkeysPsychopharmacology1731869414668977
   PubMed Web of Science ®Google Scholar
• KaymakcalanSAyhanIHTulunayFC1977Naloxone-induced or post-withdrawal abstinence signs in delta9-tetrahydrocannabinol-tolerant ratsPsychopharmacology552439414285
   PubMed Web of Science ®Google Scholar
• KauerJA2004Learning mechanisms in addiction: synaptic plasticity in the ventral tegmental area as a result of exposure to drugs of abuseAnnu Rev Physiol664477514977410
   PubMed Web of Science ®Google Scholar
• KoobGFLe MoalM2001Drug addiction, dysregulation of reward, and allostasisNeuropsychopharmacology249712911120394
   PubMed Web of Science ®Google Scholar
• KoobGF1992Drugs of abuse: anatomy, pharmacology and function of reward pathwaysTrends Pharmacol Sci13177841604710
   PubMed Web of Science ®Google Scholar
• KoobGFAhmedSHBoutrelBChenSAKennyPJMarkouAO’DellLEParsonsLHSannaPP2004Neurobiological mechanisms in the transition from drug use to drug dependenceNeurosci Biobehav Rev277394915019424
   PubMed Web of Science ®Google Scholar
• KurtzDLStewartRBZweifelM1996Genetic differences in tolerance and sensitization to the sedative/hypnotic effects of alcoholPharmacol Biochem Behav53585918866959
   PubMed Web of Science ®Google Scholar
• LallemandFSoubriePHDe WittePH2001Effects of CB1 cannabinoid receptor blockade on ethanol preference after chronic ethanol administrationAlcohol Clin Exp Res2513172311584151
   PubMed Web of Science ®Google Scholar
• Le FollBGoldbergSR2004Rimonabant, a CB1 antagonist, blocks nicotine-conditioned place preferencesNeuroreport1521394315486497
   PubMed Web of Science ®Google Scholar
• LedentCValverdeOCossuG1999Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout miceScience28340149888857
   PubMed Web of Science ®Google Scholar
• LesscherHMHoogveldEBurbachJP2005Endogenous cannabinoids are not involved in cocaine reinforcement and development of cocaine-induced behavioural sensitizationEur Neuropsychopharmacol1531715572271
   PubMed Web of Science ®Google Scholar
• LichtmanAHSheikhSMLohHH2001Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent miceJ Pharmacol Exp Ther29810071411504797
   PubMed Web of Science ®Google Scholar
• LupicaCRRiegelACHoffmanAF2004Marijuana and cannabinoid regulation of brain reward circuitsBr J Pharmacol1432273415313883
   PubMed Web of Science ®Google Scholar
• LupicaCRRiegelAC2005Endocannabinoid release from midbrain dopamine neurons: a potential substrate for cannabinoid receptor antagonist treatment of addictionNeuropharmacology4811051615878779
   PubMed Web of Science ®Google Scholar
• MaldonadoR2002Study of cannabinoid dependence in animalsPharmacol Ther951536412182962
   PubMed Web of Science ®Google Scholar
• MaldonadoRValverdeOBerrenderoF2006Involvement of the endocannabinoid system in drug addictionTrends Neurosci292253216483675
   PubMed Web of Science ®Google Scholar
• ManzanedoCAguilarMARodriguez-AriasM2004Cannabinoid agonist-induced sensitisation to morphine place preference in miceNeuroreport151373715167569
   PubMed Web of Science ®Google Scholar
• MartinMLedentCParmentierM2000Cocaine, but not morphine, induces conditioned place preference and sensitization to locomotor responses in CB1 knockout miceEur J Neurosci1240384611069600
   PubMed Web of Science ®Google Scholar
• Mas-NietoMPommierBTzavaraET2001Reduction of opioid dependence by the CB(1) antagonist SR141716A in mice: evaluation of the interest in pharmacotherapy of opioid addictionBr J Pharmacol13218091611309253
   PubMed Web of Science ®Google Scholar
• NaassilaMPierreficheOLedentC2004Decreased alcohol self-administration and increased alcohol sensitivity and withdrawal in CB1 receptor knockout miceNeuropharmacology462435314680762
   PubMed Web of Science ®Google Scholar
• NavarroMChowenJRocioA1998CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent ratsNeuroreport933974029855288
   PubMed Web of Science ®Google Scholar
• NavarroMCarreraMRFrattaW2001Functional interaction between opioid and cannabinoid receptors in drug self-administrationJ Neurosci2153445011438610
   PubMed Web of Science ®Google Scholar
• NavarroMCarreraMRDel ArcoI2004Cannabinoid receptor antagonist reduces heroin self-administration only in dependent ratsEur J Pharmacol501235715464083
   PubMed Web of Science ®Google Scholar
• NestlerEJ2004Molecular mechanisms of drug addictionNeuropharmacology47Suppl 1243215464123
   PubMed Web of Science ®Google Scholar
• OrtizSOlivaJMPerez-RialS2004Differences in basal cannabinoid CB1 receptor function in selective brain areas and vulnerability to voluntary alcohol consumption in Fawn Hooded and Wistar ratsAlcohol Alcohol3929730215208160
   PubMed Web of Science ®Google Scholar
• ParolaroDViganoDRubinoT2005Endocannabinoids and drug dependenceCurr Drug Targets CNS Neurol Disord46435516375682
   PubMedGoogle Scholar
• PierceRCKumaresanV2006The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse?Neurosci Biobehav Rev302153816099045
   PubMed Web of Science ®Google Scholar
• RiceOVGordonNGiffordAN2002Conditioned place preference to morphine in cannabinoid CB1 receptor knockout miceBrain Res945135812113961
   PubMed Web of Science ®Google Scholar
• RomeroJFernandez-RuizJJVelaG1998Autoradiographic analysis of cannabinoid receptor binding and cannabinoid agonist-stimulated [35S]GTP gamma S binding in morphine-dependent miceDrug Alcohol Depend5024199649978
   PubMed Web of Science ®Google Scholar
• RubinoTMassiPViganoD2000Long-term treatment with SR141716A, the CB1 receptor antagonist, influences morphine withdrawal syndromeLife Sci6622131910834304
   PubMed Web of Science ®Google Scholar
• SchuckitMA1994Low level of response to alcohol as a predictor of future alcoholismAm J Psychiatry15118498296886
   PubMed Web of Science ®Google Scholar
• SerraSBrunettiGPaniM2002Blockade by the cannabinoid CB(1) receptor antagonist, SR 141716, of alcohol deprivation effect in alcohol-preferring ratsEur J Pharmacol44395712044797
   PubMed Web of Science ®Google Scholar
• SerraSCaraiMABrunettiG2001The cannabinoid receptor antagonist SR141716 prevents acquisition of drinking behavior in alcohol-preferring ratsEur J Pharmacol4303697111711056
   PubMed Web of Science ®Google Scholar
• SolinasMPanlilioLVAntoniouK2003The cannabinoid CB1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive ratio schedules of drug self-administration in ratsJ Pharmacol Exp Ther3069310212660305
   PubMed Web of Science ®Google Scholar
• SolinasMPanlilioLVTandaG2005Cannabinoid agonists but not inhibitors of endogenous cannabinoid transport or metabolism enhance the reinforcing efficacy of heroin in ratsNeuropsychopharmacology3020465715870833
   PubMed Web of Science ®Google Scholar
• SoriaGMendizabalVTourinoC2005Lack of CB1 cannabinoid receptor impairs cocaine self-administrationNeuropsychopharmacology3016708015742004
   PubMed Web of Science ®Google Scholar
• SpanoMSFattoreLCossuG2004CB1 receptor agonist and heroin, but not cocaine, reinstate cannabinoid-seeking behaviour in the ratBr J Pharmacol1433435015339858
   PubMed Web of Science ®Google Scholar
• TandaGPontieriFEDi ChiaraG1997Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanismScience2762048509197269
   PubMed Web of Science ®Google Scholar
• ValjentEMitchellJMBessonMJ2002Behavioural and biochemical evidence for interactions between Delta 9-tetrahydrocannabinol and nicotineBr J Pharmacol1355647811815392
   PubMed Web of Science ®Google Scholar
• ValverdeOMaldonadoRValjentE2000Cannabinoid withdrawal syndrome is reduced in pre-proenkephalin knock-out miceJ Neurosci209284911125007
   PubMed Web of Science ®Google Scholar
• Van SickleMDDuncanMKingsleyPJMouihateAUrbaniPMackieKStellaNMakriyannisAPiomelliDDavisonJSMarnettLJDi MarzoVPittmanQJPatelKDSharkeyKA2005Identification and functional characterization of brainstem cannabinoid CB2 receptorsScience3103293216224028
   PubMed Web of Science ®Google Scholar
• VelaGRuiz-GayoMFuentesJA1995Anandamide decreases naloxone-precipitated withdrawal signs in mice chronically treated with morphineNeuropharmacology3466587566503
   PubMed Web of Science ®Google Scholar
• ViganoDRubinoTParolaroD2005Molecular and cellular basis of cannabinoid and opioid interactionsPharmacol Biochem Behav81360815927245
   PubMed Web of Science ®Google Scholar
• WangLLiuJHarvey-WhiteJ2003Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in miceProc Natl Acad Sci USA1001393812538878
   PubMed Web of Science ®Google Scholar
• WengerTMoldrichGFurstS2003Neuromorphological background of cannabis addictionBrain Res Bull61125812831997
   PubMed Web of Science ®Google Scholar
• XiZXGilbertJGPengXQ2006Cannabinoid CB1 receptor antagonist AM251 inhibits cocaine-primed relapse in rats: role of glutamate in the nucleus accumbensJ Neurosci268531616914679
   PubMed Web of Science ®Google Scholar
• YamaguchiTHagiwaraYTanakaH2001Endogenous cannabinoid, 2-arachidonoylglycerol, attenuates naloxone-precipitated withdrawal signs in morphine-dependent miceBrain Res909121611478928
   PubMed Web of Science ®Google Scholar